This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.
GlobalData on MSN22h
Dr Reddy’s and Shanghai Henlius sign agreement for HLX15Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.
CHMP Adopts Positive Opinion for Aflibercept, Pegfilgrastim Biosimilars: On January 30, 2025, the European Medicines Agency (EMA) Committee ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback